[
  {
    "ts": null,
    "headline": "Beta Bionics: A Sugar Rush For This IPO",
    "summary": "Beta Bionicsâ IPO surged with strong growth potential. Find out why BBNX stock is attractive but risky, given its competition and reliance on a single product.",
    "url": "https://finnhub.io/api/news?id=844a3d3429f79d9b4cc674c68c1cfd58157fe36b4f4274de53c8c77d40109ad5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738489400,
      "headline": "Beta Bionics: A Sugar Rush For This IPO",
      "id": 132515000,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1299608214/image_1299608214.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "Beta Bionicsâ IPO surged with strong growth potential. Find out why BBNX stock is attractive but risky, given its competition and reliance on a single product.",
      "url": "https://finnhub.io/api/news?id=844a3d3429f79d9b4cc674c68c1cfd58157fe36b4f4274de53c8c77d40109ad5"
    }
  }
]